Analysis Using Various Models on the Effect of Metabolic Surgery on Cardiovascular Disease Risk in the Chinese Population with Obesity

References

• Jaacks LM, Vandevijvere S, Pan A, et al. The obesity transition: stages of the global epidemic. Lancet Diabetes Endocrinol. 2019;7(3):231–240. doi:10.1016/S2213-8587(19)30026-9
   PubMed Web of Science ®Google Scholar
• La Sala L, Pontiroli AE. Prevention of diabetes and cardiovascular disease in obesity. Int J Mol Sci. 2020;21(21):8178. doi:10.3390/ijms21218178
   PubMed Web of Science ®Google Scholar
• Abarca-Gómez L, Abdeen ZA, Hamid ZA, et al. Worldwide trends in body-mass index, underweight, overweight, and obesity from 1975 to 2016: a pooled analysis of 2416 population-based measurement studies in 128·9 million children, adolescents, and adults. Lancet. 2017;390:2627–2642.
   PubMed Web of Science ®Google Scholar
• Huang YM, Wang W, Wei SC, et al. Evaluation of persistent efficacy of diabetes remission and decline of cardiovascular risk after laparoscopic sleeve gastrectomy: a preliminary 1-year study. OBES Surg. 2022;32(10):3289–3297. doi:10.1007/s11695-022-06201-x
   PubMed Web of Science ®Google Scholar
• Roth GA, Abate D, Abate KH, et al. Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980–2017: a systematic analysis for the global burden of disease study 2017. Lancet. 2018;392:1736–1788.
   PubMed Web of Science ®Google Scholar
• Zhou M, Wang H, Zhu J, et al. Cause-specific mortality for 240 causes in China during 1990–2013: a systematic subnational analysis for the global burden of disease study 2013. Lancet. 2016;387(10015):251–272. doi:10.1016/S0140-6736(15)00551-6
   PubMed Web of Science ®Google Scholar
• Liu Y, Douglas PS, Lip G, et al. Relationship between obesity severity, metabolic status and cardiovascular disease in obese adults. Eur J Clin Invest. 2023;53(3):e13912. doi:10.1111/eci.13912
   PubMed Web of Science ®Google Scholar
• Alpert MA, Lavie CJ, Agrawal H, Aggarwal KB, Kumar SA. Obesity and heart failure: epidemiology, pathophysiology, clinical manifestations, and management. Transl Res. 2014;164(4):345–356. doi:10.1016/j.trsl.2014.04.010
   PubMed Web of Science ®Google Scholar
• Carbone S, Lavie CJ, Arena R. Obesity and heart failure: focus on the obesity paradox. Mayo Clin Proc. 2017;92(2):266–279. doi:10.1016/j.mayocp.2016.11.001
   PubMed Web of Science ®Google Scholar
• Hotamisligil GS. Foundations of immunometabolism and implications for metabolic health and disease. Immunity. 2017;47(3):406–420. doi:10.1016/j.immuni.2017.08.009
   PubMed Web of Science ®Google Scholar
• Sebastian SA, Co EL, Kanagala SG, Padda I, Sethi Y, Johal G. Metabolic surgery in improving arterial health in obese individuals. Curr Prob Cardiol. 2024;49(3):102359. doi:10.1016/j.cpcardiol.2023.102359
   PubMed Web of Science ®Google Scholar
• Hanna A, Frangogiannis NG. Inflammatory cytokines and chemokines as therapeutic targets in heart failure. Cardiovasc Drug Ther. 2020;34(6):849–863. doi:10.1007/s10557-020-07071-0
   PubMed Web of Science ®Google Scholar
• Oliveira SC, Neves JS, Souteiro P, et al. Impact of bariatric surgery on long-term cardiovascular risk: comparative effectiveness of different surgical procedures. OBES Surg. 2020;30(2):673–680. doi:10.1007/s11695-019-04237-0
   PubMed Web of Science ®Google Scholar
• Gronroos S, Helmio M, Juuti A, et al. Effect of laparoscopic sleeve gastrectomy vs roux-en-y gastric bypass on weight loss and quality of life at 7 years in patients with morbid obesity: the sleevepass randomized clinical trial. JAMA Surg. 2021;156(2):137–146. doi:10.1001/jamasurg.2020.5666
   PubMed Web of Science ®Google Scholar
• Aminian A, Wilson R, Al-Kurd A, et al. Association of bariatric surgery with cancer risk and mortality in adults with obesity. JAMA-J Am Med Assoc. 2022;327(24):2423–2433. doi:10.1001/jama.2022.9009
   PubMed Web of Science ®Google Scholar
• Schauer DP, Feigelson HS, Koebnick C, et al. Bariatric surgery and the risk of cancer in a large multisite cohort. Ann Surg. 2019;269(1):95–101. doi:10.1097/SLA.0000000000002525
   PubMed Web of Science ®Google Scholar
• Fisher DP, Johnson E, Haneuse S, et al. Association between bariatric surgery and macrovascular disease outcomes in patients with type 2 diabetes and severe obesity. JAMA-J Am Med Assoc. 2018;320(15):1570–1582. doi:10.1001/jama.2018.14619
   PubMed Web of Science ®Google Scholar
• Singh P, Adderley N, Subramanian A, et al. The impact of bariatric surgery on incident microvascular complications in patients with type 2 diabetes: a matched controlled population-based retrospective cohort study. Diabetes Care. 2021;44(1):116–124. doi:10.2337/dc20-0571
   PubMed Web of Science ®Google Scholar
• Aminian A, Al-Kurd A, Wilson R, et al. Association of bariatric surgery with major adverse liver and cardiovascular outcomes in patients with biopsy-proven nonalcoholic steatohepatitis. JAMA-J Am Med Assoc. 2021;326(20):2031–2042. doi:10.1001/jama.2021.19569
   PubMed Web of Science ®Google Scholar
• Yang W, Zhan M, Li Z, Sun X, Zhang K. Major adverse cardiovascular events among obese patients with diabetes after metabolic and bariatric surgery: a meta-analysis of matched cohort and prospective controlled studies with 122,361 participates. OBES Surg. 2023;33(7):2098–2107. doi:10.1007/s11695-023-06634-y
   PubMed Web of Science ®Google Scholar
• Krishnan A, Hadi Y, Alqahtani SA, et al. Cardiovascular outcomes and mortality after bariatric surgery in patients with nonalcoholic fatty liver disease and obesity. JAMA Network Open. 2023;6(4):e237188. doi:10.1001/jamanetworkopen.2023.7188
   PubMed Web of Science ®Google Scholar
• Cui B, Wang G, Li P, et al. Disease-specific mortality and major adverse cardiovascular events after bariatric surgery: a meta-analysis of age, sex, and BMI-matched cohort studies. Int J Surg. 2023;109(3):389–400. doi:10.1097/JS9.0000000000000066
   PubMed Web of Science ®Google Scholar
• Jayaraman S, Perez A, Minambres I, Sanchez-Quesada JL, Gursky O. LDL binding to cell receptors and extracellular matrix is proatherogenic in obesity but improves after bariatric surgery. J Lipid Res. 2023;64(11):100451. doi:10.1016/j.jlr.2023.100451
   PubMed Web of Science ®Google Scholar
• Yan LD, Lookens PJ, Rouzier V, et al. Comparing six cardiovascular risk prediction models in Haiti: implications for identifying high-risk individuals for primary prevention. BMC Public Health. 2022;22(1):549. doi:10.1186/s12889-022-12963-x
   PubMed Web of Science ®Google Scholar
• Chen X, Tu Q, Wang D, et al. Effectiveness of China-PAR and Framingham risk score in assessment of 10-year cardiovascular disease risk in Chinese hypertensive patients. Public Health. 2023;220:127–134. doi:10.1016/j.puhe.2023.05.007
   PubMed Web of Science ®Google Scholar
• Kasim SS, Ibrahim N, Malek S, et al. Validation of the general Framingham Risk Score (FRS), SCORE2, revised PCE and WHO CVD risk scores in an Asian population; 2023.
   Google Scholar
• Riddle MC, Cefalu WT, Evans PH, et al. Consensus report: definition and interpretation of remission in type 2 diabetes. Diabetes Care. 2021;44(10):2438–2444. doi:10.2337/dci21-0034
   PubMed Web of Science ®Google Scholar
• Wang R, Olier I, Ortega-Martorell S, et al. Association between metabolically healthy obesity and risk of atrial fibrillation: taking physical activity into consideration. Cardiovasc Diabetol. 2022;21(1):208. doi:10.1186/s12933-022-01644-z
   PubMed Web of Science ®Google Scholar
• Lopez-Jimenez F, Almahmeed W, Bays H, et al. Obesity and cardiovascular disease: mechanistic insights and management strategies. A joint position paper by the World Heart Federation and World Obesity Federation. Eur J Prev Cardiol. 2022;29(17):2218–2237. doi:10.1093/eurjpc/zwac187
   PubMed Web of Science ®Google Scholar
• Fuster JJ, Ouchi N, Gokce N, Walsh K. Obesity-induced changes in adipose tissue microenvironment and their impact on cardiovascular disease. Circ Res. 2016;118(11):1786–1807. doi:10.1161/CIRCRESAHA.115.306885
   PubMed Web of Science ®Google Scholar
• Shah MS, Brownlee M. Molecular and cellular mechanisms of cardiovascular disorders in diabetes. Circ Res. 2016;118(11):1808–1829. doi:10.1161/CIRCRESAHA.116.306923
   PubMed Web of Science ®Google Scholar
• Lakka HM, Lakka TA, Tuomilehto J, Salonen JT. Abdominal obesity is associated with increased risk of acute coronary events in men. Eur Heart J. 2002;23(9):706–713. doi:10.1053/euhj.2001.2889
   PubMed Web of Science ®Google Scholar
• Janssen I, Katzmarzyk PT, Ross R. Waist circumference and not body mass index explains obesity-related health risk. Am J Clin Nutr. 2004;79(3):379–384. doi:10.1093/ajcn/79.3.379
   PubMed Web of Science ®Google Scholar
• Wang Z, Hoy WE. Waist circumference, body mass index, Hip circumference and waist-to-Hip ratio as predictors of cardiovascular disease in Aboriginal people. Eur J Clin Nutr. 2004;58(6):888–893. doi:10.1038/sj.ejcn.1601891
   PubMed Web of Science ®Google Scholar
• Ponce DLG, Sanchez-Aguilar HA, Aguilar-Salinas CA, Herrera MF. Reaching LDL-C targets in patients with moderate, high, and very high risk for cardiovascular disease after bariatric surgery according to different guidelines. OBES Surg. 2021;31(5):2087–2096. doi:10.1007/s11695-021-05221-3
   PubMed Web of Science ®Google Scholar
• Iqbal Z, Bashir B, Adam S, et al. Glycated apolipoprotein B decreases after bariatric surgery in people with and without diabetes: a potential contribution to reduction in cardiovascular risk. Atherosclerosis. 2022;346:10–17. doi:10.1016/j.atherosclerosis.2022.01.005
   PubMed Web of Science ®Google Scholar
• Rubio-Almanza M, Camara-Gomez R, Hervas-Marin D, Ponce-Marco JL, Merino-Torres JF. Cardiovascular risk reduction over time in patients with diabetes or pre-diabetes undergoing bariatric surgery: data from a single-center retrospective observational study. BMC Endocr Disord. 2018;18(1):90. doi:10.1186/s12902-018-0317-4
   PubMedGoogle Scholar
• Adam S, Ho JH, Liu Y, et al. Bariatric surgery-induced high-density lipoprotein functionality enhancement is associated with reduced inflammation. J Clin Endocr Metab. 2022;107(8):2182–2194. doi:10.1210/clinem/dgac244
   PubMed Web of Science ®Google Scholar
• Gordon T, Castelli WP, Hjortland MC, Kannel WB, Dawber TR. High density lipoprotein as a protective factor against coronary heart disease. The Framingham Study. Am J Med. 1977;62(5):707–714. doi:10.1016/0002-9343(77)90874-9
   PubMed Web of Science ®Google Scholar
• Xue H, Zhang M, Liu J, Wang J, Ren G. Structure-based mechanism and inhibition of cholesteryl ester transfer protein. Curr Atheroscler Rep. 2023;25(4):155–166. doi:10.1007/s11883-023-01087-1
   PubMed Web of Science ®Google Scholar
• Stadler JT, Marsche G. Obesity-related changes in high-density lipoprotein metabolism and function. Int J Mol Sci. 2020;21(23):8985. doi:10.3390/ijms21238985
   PubMed Web of Science ®Google Scholar
• Chew C, Tan IJ, Ng H, Lomanto D, So J, Shabbir A. Early weight loss after laparoscopic sleeve gastrectomy predicts midterm weight loss in morbidly obese Asians. Surg OBES Relat Dis. 2017;13(12):1966–1972. doi:10.1016/j.soard.2017.05.016
   PubMed Web of Science ®Google Scholar
• Schauer PR, Bhatt DL, Kirwan JP, et al. Bariatric surgery versus intensive medical therapy for diabetes--3-year outcomes. New Engl J Med. 2014;370(21):2002–2013. doi:10.1056/NEJMoa1401329
   PubMed Web of Science ®Google Scholar
• Ma S, Wang L, Chen J, Zhao Y, Jiang T. The effect of laparoscopic sleeve gastrectomy on type 2 diabetes remission outcomes in patients with body mass index between 25 kg/m 2 and 32.5 kg/m 2. Asian J Surg. 2022;45(1):315–319. doi:10.1016/j.asjsur.2021.06.001
   PubMed Web of Science ®Google Scholar
• Elsaid MI, Li Y, Bridges J, Brock G, Minacapelli CD, Rustgi VK. Association of bariatric surgery with cardiovascular outcomes in adults with severe obesity and nonalcoholic fatty liver disease. JAMA Network Open. 2022;5(10):e2235003. doi:10.1001/jamanetworkopen.2022.35003
   PubMed Web of Science ®Google Scholar
• Ke Z, Li F, Zhou X, Sun F, Zhu Z, Tong W. Impact of metabolic surgery on 10-year cardiovascular disease risk in Chinese individuals with type 2 diabetes. Surg OBES Relat Dis. 2021;17(3):498–507. doi:10.1016/j.soard.2020.11.013
   PubMed Web of Science ®Google Scholar